Back to mobile site

Leerink Partners Downgrades Edwards Lifesciences (EW) to Market Perform

February 2, 2017 9:34 AM EST Send to a Friend
Leerink Partners downgraded Edwards Lifesciences (NYSE: EW) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login